| West Virginia Oncology Society |
An analysis of data from the Nurse’s Health Study, a large, ongoing prospective observational
study, shows that women who have completed treatment for early-stage breast cancer and who
take aspirin have a nearly 50 percent reduced risk of breast cancer death and a similar reduction in
the risk of metastasis.
“This is the first study to find that aspirin can significantly reduce the risk of cancer spread and
death for women who have been treated for early-stage breast cancer, " said Michelle Holmes, MD,
DrPH, associate professor of medicine and epidemiology at Harvard Medical School & Harvard
School of Public Health and the study's lead author. “If these findings are confirmed in other clinical
trials, taking aspirin may become another simple, low-cost and relatively safe tool to help women
with breast cancer live longer, healthier lives."
To read the complete article CLICK HERE.
study, shows that women who have completed treatment for early-stage breast cancer and who
take aspirin have a nearly 50 percent reduced risk of breast cancer death and a similar reduction in
the risk of metastasis.
“This is the first study to find that aspirin can significantly reduce the risk of cancer spread and
death for women who have been treated for early-stage breast cancer, " said Michelle Holmes, MD,
DrPH, associate professor of medicine and epidemiology at Harvard Medical School & Harvard
School of Public Health and the study's lead author. “If these findings are confirmed in other clinical
trials, taking aspirin may become another simple, low-cost and relatively safe tool to help women
with breast cancer live longer, healthier lives."
To read the complete article CLICK HERE.
| Large Analysis Finds Breast Cancer Patients Who Take Aspirin Reduced Risk of Metastasis and Death by Half |
American Society of Clinical Oncology (ASCO)